ANI Pharmaceuticals, Inc. Reports 38% Advance In Q3 Profit

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) reported earnings for its third quarter that gained ground compared to the same period last year.

The company said its bottom line rose to $9.29 million, or $0.80 per share. This was up from $6.75 million, or $0.59 per share, in last year's third quarter.

The company said revenue for the quarter rose 14.8% to $19.97 million. This was up from $17.39 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q3): $9.29 Mln. vs. $6.75 Mln. last year. -Earnings Growth (Y-o-Y): 37.6% -EPS (Q3): $0.80 vs. $0.59 last year. -EPS Growth (Y-o-Y): 35.6% -Revenue (Q3): $19.97 Mln vs. $17.39 Mln last year. -Revenue Change (Y-o-Y): 14.8%

-Guidance: Next quarter EPS guidance: $0.63 - $0.76 Next quarter revenue guidance: $17.2 - $20.0 Mln Full year EPS guidance: $2.83 - $2.96 Full year revenue guidance: $75.5 - $78.3 Mln